SARASOTA, Fla. -- In its continuing efforts to get medicinal cannabinoids to patients as quickly as possible, Neutra Corp. (OTCBB: NTRR) subsidiary Cannabis Technologies, Inc., announced today a new joint venture with Vertigo Technologies, LLC, a cutting-edge developer of cannabis post-production processes.

NTRR will work with Vertigo Technologies to advance the development and marketing of innovative horticulture systems. With this partnership, NTRR, a rapidly growing provider of all-natural wellness solutions, is taking the next step in capturing a share of the booming $1.7 billion medical marijuana (MMJ) market forecast to reach $6 billion over the next five years.

“Vertigo Technologies’ company focus is on the entire production cycle,” NTRR CEO Sydney Jim said. “Our goal is to bring advanced technology to this burgeoning industry and achieve efficiency and quality for the products and services we deliver.”

Through its subsidiary, Cannabis Technologies, NTRR is working to help introduce the next wave of healthier, more efficient delivery systems to the ever-growing MMJ market. By providing innovative nutraceutical products and services such as new MMJ breakthroughs, Neutra Corp. plans to follow in the footsteps of other successful public companies including Cannabis Science, Inc. (OTCBB: CBIS), Medical Marijuana Inc. (OTCBB: MJNA) and Terra Tech Corp. (OTCBB: TRTC), delivering technological advancements in the cultivation and processing of cannabis in approved markets.

For more information on NTRR’s initiatives, please visit www.neutracorp.com.

About Neutra Corp.

Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. For investing information and performance data, please visit www.neutracorp.com.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.